Ausgabe 5/2016
Inhalt (15 Artikel)
Cyclin D1 and cyclin E2 are differentially expressed in gastric cancer
Soni Kumari, Puneet, Shyam Babu Prasad, Suresh Singh Yadav, Mohan Kumar, A. Khanna, V. K. Dixit, Gopal Nath, Sunita Singh, Gopeshwar Narayan
Hypoxia regulates stemness of breast cancer MDA-MB-231 cells
Jing Xie, Yong Xiao, Xiao-yan Zhu, Zhou-yu Ning, Hai-fan Xu, Hui-min Wu
BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer
Kuo-Hsing Chen, Yu-Lin Lin, Jau-Yu Liau, Jia-Huei Tsai, Li-Hui Tseng, Liang-In Lin, Jin-Tung Liang, Been-Ren Lin, Ji-Shiang Hung, Yih-Leong Chang, Kun-Huei Yeh, Ann-Lii Cheng
Potential of sulfasalazine as a therapeutic sensitizer for CD44 splice variant 9-positive urogenital cancer
Tatsuya Takayama, Taro Kubo, Ai Morikawa, Tatsuo Morita, Osamu Nagano, Hideyuki Saya
FGFR3 promotes angiogenesis-dependent metastasis of hepatocellular carcinoma via facilitating MCP-1-mediated vascular formation
Xinyu Liu, Xiaoqian Jing, Xi Cheng, Ding Ma, Zhijian Jin, Weiping Yang, Weihua Qiu
Cost description of chemotherapy regimens for the treatment of metastatic pancreas cancer
Daniel A. Goldstein, Kavya Krishna, Christopher R. Flowers, Bassel F. El-Rayes, Tanios Bekaii-Saab, Anne M. Noonan
Assessment of the frequency of genetic alterations (LOH/MSI) in patients with intraepithelial cervical lesions with HPV infection: a pilot study
Monika Migdalska-Sęk, Agata Karowicz-Bilińska, Dorota Pastuszak-Lewandoska, Karolina H. Czarnecka, Ewa Nawrot, Daria Domańska-Senderowska, Justyna Kiszałkiewicz, Ewa Brzeziańska-Lasota
Risk of interactions between complementary and alternative medicine and medication for comorbidities in patients with melanoma
Carmen Loquai, Dagmar Dechent, Marlene Garzarolli, Martin Kaatz, Katharina C. Kaehler, Peter Kurschat, Frank Meiss, Annette Stein, Dorothee Nashan, Oliver Micke, Ralph Muecke, Karsten Muenstedt, Christoph Stoll, Irene Schmidtmann, Jutta Huebner
HDAC6-mediated EGFR stabilization and activation restrict cell response to sorafenib in non-small cell lung cancer cells
Zhihao Wang, Pengchao Hu, Fang Tang, Conghua Xie
Inhibition of glioblastoma cell proliferation, migration and invasion by the proteasome antagonist carfilzomib
Zammam Areeb, Stanley S. Stylli, Thomas M. B. Ware, Nicole C. Harris, Lipi Shukla, Ramin Shayan, Lucia Paradiso, Bo Li, Andrew P. Morokoff, Andrew H. Kaye, Rodney B. Luwor
Clinical significance of circulating miRNA detection in lung cancer
Chen Zhao, Funian Lu, Hongxia Chen, Fuqiang Zhao, Ziwen Zhu, Xianda Zhao, Honglei Chen
Targeting persistent androgen receptor signaling in castration-resistant prostate cancer
Laura Graham, Michael T. Schweizer
Translating microRNAs into biomarkers: What is new for pediatric cancer?
Ivna Néria Silva Ribamar de Carvalho, Renata Mendes de Freitas, Fernando Regla Vargas
Peptide receptor radionuclide therapy for metastatic paragangliomas
David J. Pinato, James R. M. Black, Ramya Ramaswami, Tricia M. Tan, Delali Adjogatse, Rohini Sharma